Piero Olliaro

Biographic Data

ID7003392
NAMEPiero Olliaro
GIVEN NAMESPiero
FAMILY NAMEOlliaro
SIGNATUREOLLIARO P
AFFILIATIONSUniversity of Oxford
ORCID0000-0003-1426-3680
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS0
AUTHOR COUNT8
EDITOR COUNT0
FIRST PUBLICATION YEAR2002
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Visceral leishmaniasis elimination in South Asia

    Open AccessPiero Olliaro, Dinesh Mondal et al.ARTICLEBMJ Global Health2026

    In 2005, the governments of Bangladesh, India and Nepal, in partnership with the WHO, started the Kala-azar Elimination Programme (KEP) to reduce the incidence of visceral leishmaniasis to below 1 new case in 10 000 population. The target was achieved by Bangladesh in 2017 and validated in 2023. The KEP has demonstrated that, through a concerted approach and public–private partnership, it is possible to eliminate visceral leishmaniasis from the w…

  • The priority review voucher

    Open AccessPiero Olliaro, Els TorreeleARTICLEBMJ Global Health2024

    WHAT IS ALREADY KNOWN ON THIS TOPIC The US Food and Drug Administration (FDA) Priority Review Voucher (PRV) is one of a set of push-and-pull mechanisms to incentivise investments into medical innovation for otherwise neglected, non-profitable diseases for pharmaceutical companies and investors, but its effectiveness has been questioned

  • The facilitators of and barriers to antimicrobial use and misuse in Lalitpur, Nepal

    Open AccessSummita Udas, Obindra Chand et al.ARTICLEBMC Public Health2024

    Overall, the results of this study provide a nuanced understanding of the challenges associated with antibiotic use and suggest that tailored interventions, informed by behaviour frameworks, can enhance prescription adherence, may be applicable in diverse settings and can contribute to the global effort to mitigate the rising threat of AMR

  • Addressing stigma in infectious disease outbreaks

    Open AccessAmy Paterson, Piero Olliaro et al.ARTICLEFrontiers in Public Health2023

    There is a complex interplay between infectious disease outbreaks and the stigmatization of affected persons and communities. Outbreaks are prone to precipitating stigma due to the fear, uncertainty, moralisation, and abatement of freedoms associated with many infectious diseases. In turn, this stigma hampers outbreak control efforts. Understanding this relationship is crucial to improving coordinated outbreak response. This requires valid and re…

  • Global burden of bacterial antimicrobial resistance in 2019

    Open AccessChristopher J L Murray, Kevin S Ikuta et al.ARTICLEThe Lancet2022

    BACKGROUND: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. METHODS: We estimated deaths and disability-adjusted life-years (DALYs) a…

  • Characterising long Covid

    Open AccessMelina Michelen, Lakshmi Manoharan et al.ARTICLEBMJ Global Health2021

  • Global health security

    Open AccessDavid L Heymann, Lincoln Chen et al.ARTICLEThe Lancet2015

    The Ebola virus disease outbreak in West Africa was unprecedented in both its scale and impact. Out of this human calamity has come renewed attention to global health security--its definition, meaning, and the practical implications for programmes and policy. For example, how does a government begin to strengthen its core public health capacities, as demanded by the International Health Regulations? What counts as a global health security concern…

  • Drug development for neglected diseases

    Open AccessPatrice Trouiller, Piero Olliaro et al.ARTICLEThe Lancet2002